Bionano Genomics Inc
NASDAQ:BNGO

Watchlist Manager
Bionano Genomics Inc Logo
Bionano Genomics Inc
NASDAQ:BNGO
Watchlist
Price: 1.55 USD -1.9% Market Closed
Market Cap: 15.8m USD

Wall Street
Price Targets

BNGO Price Targets Summary
Bionano Genomics Inc

Wall Street analysts forecast BNGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNGO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

Lowest
Price Target
7.07 USD
356% Upside
Average
Price Target
7.65 USD
394% Upside
Highest
Price Target
8.4 USD
442% Upside
Bionano Genomics Inc Competitors:
Price Targets
TQB0
MindWalk Holdings Corp
41% Upside
688238
Obio Technology Shanghai Corp Ltd
37% Upside
NANOFH
Nanoform Finland Oyj
187% Upside
603259
WuXi AppTec Co Ltd
25% Upside
DHR
Danaher Corp
12% Upside
300463
Maccura Biotechnology Co Ltd
27% Upside
RPID
Rapid Micro Biosystems Inc
122% Upside
688114
MGI Tech Co Ltd
10% Upside

Revenue
Forecast

Revenue Estimate
Bionano Genomics Inc

For the last 7 years the compound annual growth rate for Bionano Genomics Inc's revenue is 18%. The projected CAGR for the next 4 years is 21%.

18%
Past Growth
21%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Bionano Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Bionano Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-95%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNGO's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for BNGO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

What is Bionano Genomics Inc's Revenue forecast?
Projected CAGR
21%

For the last 7 years the compound annual growth rate for Bionano Genomics Inc's revenue is 18%. The projected CAGR for the next 4 years is 21%.

Back to Top